Deuruxolitinib: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Deuruxolitinib. Educational only — not medical advice.
Labeled uses
LEQSELVI™ is indicated for the treatment of adult patients with severe alopecia areata. Limitations of Use LEQSELVI is not recommended for use in combination with other JAK inhibitors, biologic immunomodulators, cyclosporine, or other potent immunosuppressants.
Source: FDA labeling via NIH DailyMed (set a603f231…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.